Invivyd’s C‑Suite Unites in Massive Option Grants Amid Volatile Market, Signaling Bold Insider Confidence
Invivyd insiders’ synchronized stock‑option buys signal confidence; CFO’s 625k‑share grant and 2.8M options suggest the company may rebound to $3.07 after key COVID‑19 antibody milestones.
3 minutes to read